F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
出版年份 2013 全文链接
标题
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
作者
关键词
-
出版物
LEUKEMIA
Volume 27, Issue 11, Pages 2139-2148
出版商
Springer Nature
发表日期
2013-04-09
DOI
10.1038/leu.2013.108
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
- (2013) Anna V. Knizhnik et al. PLoS One
- Elacytarabine: lipid vector technology under investigation in acute myeloid leukemia
- (2013) Niamh Keane et al. Expert Review of Hematology
- Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer
- (2012) Chi-Iou Lin et al. SURGERY
- Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II
- (2011) Caroline Ballot et al. APOPTOSIS
- Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II
- (2011) Viviane Brel et al. BIOCHEMICAL PHARMACOLOGY
- Interactions between the Etoposide Derivative F14512 and Human Type II Topoisomerases: Implications for the C4 Spermine Moiety in Promoting Enzyme-Mediated DNA Cleavage
- (2011) Amanda C. Gentry et al. BIOCHEMISTRY
- Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126
- (2011) Auke D. Adema et al. INVESTIGATIONAL NEW DRUGS
- An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II
- (2011) Sonia Chelouah et al. PLoS One
- Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo
- (2010) Caroline D. Scatena et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment
- (2010) J.-P. Annereau et al. LEUKEMIA RESEARCH
- AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
- (2009) A. Oke et al. CANCER RESEARCH
- Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system
- (2009) Anna Kruczynski et al. INVESTIGATIONAL NEW DRUGS
- F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System
- (2008) J.-M. Barret et al. CANCER RESEARCH
- Cooperating gene mutations in acute myeloid leukemia: a review of the literature
- (2008) A Renneville et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now